SENS

Senseonics Holdings, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$10.04

Price (1 Year)

$10.04 $4.86

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %17.5 / %30
Non-compliant assets / Total market cap %36.4 / %30
Non-compliant revenue / Total income %6.1 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.

Website

Analysis (Turkish): SENS Hissesi Caiz mi, Helal mi? Senseonics Holdings, Inc. Katılım Analizi